| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Outsourcing > Who to Outsource in Today's Competitive Marketplace? An Idea About Where India and China Stand? |
|
Main Subject - Who to Outsource in Today's Competitive Marketplace? An Idea About Where India and China Stand?
Outsourcing! Dazed of its popularity? But do you really know why outsourcing is the most highlighting trend in the IT industry today? And who are the major contenders? Le According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product t’s have a smart idea about outsourcing and its ongoing emergence. In simpler words, to concentrate more on the core competencies and target business, global companies dr ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ive their software jobs to low wage countries like India which provides not only the low priced quality product on time but also a healthy experience and long term busine lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ss relationships. Despite all hues and cries, outsourcing is still emerging as a preferred practice in developed countries to take advantage of resources and trained manp here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ower of offshore countries like India, China, Philippines, etc. And it would really be a strategic howler for any company or organization today not to think about outsour d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro cing as a strategic and significant initiative to thrive & even survive in current marketplace. Almost every vigilant company is considerate about outsourcing bearing in ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc mind the need of the market, for high quality work done at competitive prices. Now question is who to go for? There are so many contenders for providing services at low easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi rices. But there are many other things beyond prices nowadays that are considered. Be it knowledge processing or software outsourcing, the Chinese tech economy has been r nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically acing forward, but neighbor India has achieved an easy lead in the field of software outsourcing and other Hi-tech jobs coming from offshore European and other global com and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ panies. Recently, one of the consulting firms revealed its analysis saying that fragmentation of China's software-outsourcing industry is a limitation. Out of over 8000 ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi software service providers in China, only 7-8 have more than 2000 employees. On the contrary, India has fewer than 3,000 software services providers but more than 15 of t ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a he companies have employee strength beyond 2000, including major software, like Infosys Technologies, Tata Consultancy Services and Wipro Technologies. Furthermore, reven dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ue from information technology services in China is just about half of India's $12.7 billion a year. It is completely true and hard fact that outsourcing has shared the cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin jobs of European countries but same way these global organizations are contended with the low priced and high quality services from Indian service providers. Overall, def tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nders advocates outsourcing that actually help the US economy. No doubt, China is having a workforce of talented minds but things, like lower number of employees, communi t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel cation and language problem hampers the way to outsourcing. Apart from great English speaking strength, the processes followed by Indian companies are performed in a rigo ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rous environment assuring, testing and confirming the strength and solid quality of the products and services. Well, y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products opment.html" target="_blank">outsourcing software development and other services and projects to lower-wage nations is in some ways believed as an ev . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de olution of the overseas flow of manufacturing work. Today, if China has been a manufacturing leader, India has appeared as an all rounder and the king in providing servic elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Leading Change - A Manifesto for Change Good Manners Mean Good Business
|